| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |